Comments on - Neoadjuvant Chemo-radiation with IMRT in Resectable and Borderline Resectable Pancreatic Cancer

DOI QR Code

Pathy, Sushmita (Department of Radiation Oncology, Dr.B.R.Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences) ;
Francis, Antony George (Department of Radiation Oncology, Dr.B.R.Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences) ;
Roy, Soumyajit (Department of Radiation Oncology, Dr.B.R.Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences)

Caravatta L, Sallustio G, Pacelli F, et al (2012). Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer. Radiat Oncol, 7, 86. https://doi.org/10.1186/1748-717X-7-86
Kharofa J, Tsai S, Kelly T, et al (2014). Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer. Radiother Oncol, 113, 41-6. https://doi.org/10.1016/j.radonc.2014.09.010
Lopez NE, Prendergast C, Lowy AM (2014) Borderline resectable pancreatic cancer: definitions and management. World J Gastroenterol, 20, 10740-51. https://doi.org/10.3748/wjg.v20.i31.10740